NCT04309071

Brief Summary

Recent evidence suggests that hyperinsulinemia (i.e., elevated insulin levels) is the primary causative factor in obesity. Insulin promotes fat storage and prevents fat breakdown, suggesting that weight loss would be optimized if insulin levels are managed and kept low. Understanding how different foods impact insulin levels could therefore aid in personalized weight loss (or weight maintenance) advice. It has been shown that salivary insulin can track plasma insulin following different meals and can delineate between lean and obese people. Thus, it was suggested that salivary insulin could be a potential surrogate for plasma insulin. The purpose of this study is to measure fasting saliva insulin, and salivary insulin responses to a standardized meal tolerance test in individuals with different body mass index (BMI).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 4, 2019

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

March 11, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 16, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

September 28, 2021

Status Verified

September 1, 2021

Enrollment Period

3.4 years

First QC Date

March 11, 2020

Last Update Submit

September 27, 2021

Conditions

Keywords

Salivary insulin

Outcome Measures

Primary Outcomes (2)

  • Saliva insulin area under the curve

    The saliva insulin concentration measured by enzyme-linked immunosorbent assay - Area under the curve will be measured using the trapezoidal rule.

    Measured for 90 minutes following the meal (time points: fasting, 60 minutes, and 90 minutes)

  • Saliva insulin at different time points

    Saliva insulin will be collected and measured by enzyme-linked immunosorbent assay.

    Salivary insulin at fasting (at least 4 hours of fasting), and at 60 and 90 minutes following mixed meal ingestion)

Secondary Outcomes (2)

  • Glucose area under the curve

    Measured for 90 minutes following the meal (time points: fasting, 60 minutes, and 90 minutes)

  • Glucose

    Finger prick glucose will be measured at fasting (at least 4 hours of fasting), and at 60 and 90 minutes following mixed meal ingestion)

Study Arms (1)

Salivary insulin responses to mixed meal tolerance test

EXPERIMENTAL

Saliva samples and finger prick glucose will be collected after at least 4 hours of fasting and then at 60 and 90 minutes following ingestion of a standardized meal tolerance test.

Other: Dietary intervention

Interventions

Salivary insulin responses to a standardized mixed meal

Salivary insulin responses to mixed meal tolerance test

Eligibility Criteria

Age18 Years - 69 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • non-smoker
  • have a body mass index greater than 18.5 kg/m2
  • have not been diagnosed with type 2 diabetes or other medical conditions affecting glucose or insulin levels

You may not qualify if:

  • You have been. diagnosed with diabetes (fasting blood sugar more than 7.0 mmol/l) or any other diagnosed chronic condition that may impact your glucose or insulin levels or the outcomes of this study.
  • You take any medication which may affect your glucose and insulin level
  • Unable to travel to make your testing appointments.
  • Unable to consume the meal tolerance test drink/shake and/or provide finger stick glucose or saliva samples for the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of British Columbia Okanagan

Kelowna, British Columbia, V1V 3G1, Canada

RECRUITING

MeSH Terms

Conditions

Insulin ResistanceHyperinsulinism

Interventions

Diet Therapy

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Nutrition TherapyTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 11, 2020

First Posted

March 16, 2020

Study Start

January 4, 2019

Primary Completion

June 1, 2022

Study Completion

September 1, 2022

Last Updated

September 28, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations